ResoTher Pharma A/S: Financial statements 2019
CVR: 37852406
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
ResoTher Pharma A/S (CVR 37852406) has filed annual accounts for 2019. In 2019, the company reported a net result of DKK -3,916,000 compared with DKK -2,412,666 the year before. Equity in the 2019 report amounted to DKK 1,712,000. The solvency ratio was 31.5%.
- Profit/Loss
- DKK -3,916,000
- Equity
- DKK 1,712,000
- Total Assets
- DKK 5,438,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | - | -3.9 mio. | 1.7 mio. | - |
| 2018 | - | -2.1 mio. | -2.4 mio. | -1.5 mio. | 1 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
ResoTher Pharma A/S has published its annual report for 2018. Gross profit came to DKK -2,070,952, and the net result was DKK -2,412,666.
As of May 29, 2019, EY Godkendt Revisionspartnerselskab has been appointed auditor of ResoTher Pharma A/S.
As of May 29, 2019, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of ResoTher Pharma A/S.
As of May 29, 2019, Lars Henning Stigel has joined the board of directors of ResoTher Pharma A/S.
As of May 29, 2019, Mette Munch has left the board of directors of ResoTher Pharma A/S.
About ResoTher Pharma A/S
ResoTher Pharma A/S is a Danish company of the type Aktieselskab based in Holte, founded in 2016. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named ResoTher Pharma ApS. The management consists of Anders Kronborg. The board consists of Rebecca Anne Morison (chair), Henrik Stage, Jeppe Øvli Øvlesen and Michael Østerlund Madsen. The company is owned by Quantass ApS and TJ Biotech Holding ApS. The company has 4 employees (2026). Equity in the 2025 report amounted to DKK 12,132,000.